Berlin - Delayed Quote EUR

Faron Pharmaceuticals Oy (4FR.BE)

Compare
2.1900
-0.0200
(-0.90%)
As of 12:56:05 PM GMT+1. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
10,220.0000
11,271.0000
13,182.0000
8,367.0000
Total Liabilities Net Minority Interest
25,381.0000
22,747.0000
10,263.0000
10,216.0000
Total Equity Gross Minority Interest
-15,161.0000
-11,476.0000
2,919.0000
-1,849.0000
Total Capitalization
-5,738.0000
-374.0000
5,837.0000
879.0000
Common Stock Equity
-15,161.0000
-11,476.0000
2,919.0000
-1,849.0000
Capital Lease Obligations
213.0000
316.0000
200.0000
375.0000
Net Tangible Assets
-16,249.0000
-12,630.0000
2,020.0000
-2,414.0000
Working Capital
-6,144.0000
-741.0000
4,845.0000
868.0000
Invested Capital
-2,263.0000
1,477.0000
6,266.0000
1,001.0000
Tangible Book Value
-16,249.0000
-12,630.0000
2,020.0000
-2,414.0000
Total Debt
13,111.0000
13,269.0000
3,547.0000
3,225.0000
Net Debt
6,023.0000
5,963.0000
--
--
Share Issued
68,786.6990
59,805.3830
53,232.0320
46,896.7470
Ordinary Shares Number
68,786.6990
59,805.3830
53,232.0320
46,896.7470
12/31/2020 - 1/21/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers